Kantaro's COVID-SeroKlir Antibody Test Named as a Finalist for FastCompany's 2021 World Changing Ideas Awards
Kantaro Biosciences, LLC, a joint venture between the Mount Sinai Health System and RenalytixAI, announced that COVID-SeroKlir, itssemi-quantitative SARS-CoV-2 IgG antibody test, was named as a finalistin the Pandemic Response category of Fast Company's 2021 WorldChanging Ideas Awards.